BioWorld

Sep. 12, 2000

View Archived Issues

Immunicon Raises $22M, Strengthens J&J Relationship

Read More

Genzyme To Pay $1B In Cash, Stock For Renagel Partner GelTex

Read More

HGS Gains Principia's Albumin Fusion Platform For $120 M In Stock

Read More

Heparin's Oddest-Ball Molecular Sequence Yields To MIT Biotech Group's Analytical Tool Formula

Read More

Vertex Plans $200M Offering, $175M Note Redemption

Read More

Other News To Note

Read More

Alliance Stock Jumps 11 Percent On Positive Oxygent Phase III Data

Read More